Cochrane · systematic review · CD011109
Probing for congenital nasolacrimal duct obstruction
Petris, C, Liu, D · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
3
No studies
2
Included studies
NR
No studies 2 · 40%Ungraded 0 · 0%Very low 1 · 20%Low 0 · 0%Moderate 2 · 40%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: children with congenital nasolacrimal duct obstruction (NLDO)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Treatment success (at 6 months) | no estimate extracted | NR | Moderate Downgraded: risk of bias |
Treatment success (at other time points) | RR 1.13 [0.99, 1.28] | 1 study · 146 participants | Very low Downgraded: risk of bias, imprecision, inconsistency |
Proportion of participants requiring secondary procedures | no estimate extracted | NR | No studies |
Cost‐effectiveness | no estimate extracted | 1 study · 163 participants | Moderate |
Complications | no estimate extracted | NR | No studies |